---
title: "Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688321.SH.md"
symbol: "688321.SH"
name: "Shenzhen Chipscreen Biosciences Co., Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-21T01:34:34.817Z"
locales:
  - [en](https://longbridge.com/en/quote/688321.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688321.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688321.SH.md)
---

# Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SH)

## Company Overview

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selective inhibitor; CS32582, a highly selective small-molecule allosteric inhibitor of tyrosine kinase 2; CS12088, a hepatitis B nucleocapsid assembly modulator; and CS12192 a highly selective JAK3 kinase inhibitor.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.chipscreen.com](https://www.chipscreen.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.37)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 45.71% |  |
| Net Profit YoY | 185.24% |  |
| P/B Ratio | 5.29 |  |
| Dividend Ratio | 0.20% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12912518239.09 |  |
| Revenue | 1006624087.72 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.75% | C |
| Profit Margin | 9.79% | B |
| Gross Margin | 85.80% | A |
| Revenue YoY | 45.71% | A |
| Net Profit YoY | 185.24% | A |
| Total Assets YoY | 38.36% | A |
| Net Assets YoY | 65.48% | A |
| Cash Flow Margin | 102.99% | C |
| OCF YoY | 45.71% | A |
| Turnover | 0.25 | D |
| Gearing Ratio | 43.59% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shenzhen Chipscreen Biosciences Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "45.71%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "185.24%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "5.29",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.20%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12912518239.09",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1006624087.72",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.75%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "9.79%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "85.80%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "45.71%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "185.24%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "38.36%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "65.48%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "102.99%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "45.71%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.25",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "43.59%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 130.65 | 149/215 | 1799.39 | 1636.42 | 265.80 |
| PB | 5.28 | 190/215 | 9.16 | 8.01 | 5.64 |
| PS (TTM) | 12.79 | 195/215 | 17.90 | 15.25 | 13.68 |
| Dividend Yield | 0.20% | 146/215 | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2024-12-01T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 29.53 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688321.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688321.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688321.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/688321.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**